MedTrace Logo

Early Cancer Detection Test - Lung Cancer Scotland

NCT01925625 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12210

Last updated 2018-10-16

No results posted yet for this study

Summary

HYPOTHESIS In a high risk population the EarlyCDT-Lung test reduces the incidence of late stage tumours;3 / 4 / Unclassified (U) at diagnosis compared to normal clinical practice.

Conditions

Interventions

BIOLOGICAL

Early CDT Lung blood test

The EarlyCDT-Lung Test is an early detection test designed to assist in lung cancer risk assessment and detection in the earliest stages of the disease.

Sponsors & Collaborators

  • Stuart Schembri

    lead OTHER

Principal Investigators

  • Frank Sullivan, MbChB · University of Dundee

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01925625 on ClinicalTrials.gov